And at #IMFIMWG26, Mr. New York takes on “Hotel California”… And not just crushes it, he knocks it to MRD neg at 10^-8 in 30 seconds 👏 Bravo @JoshuaRichterMD for 🎸 performance of the year!

Move over myeloma...

Myeloma is now becoming a curable disease because the myeloma family works so well together. Celebrating the spirit of collaboration with the Plasma Cells at #IMWG26. Thanks to @VincentRK and the entire @IMFmyeloma leadership for bringing us all to the table. #mmsm

#mmsm #IMWG26 One important discussion point brought by @VincentRK was to be careful about the assumption that PERSEUS study PFS will be 17 yrs While outcomes are great with quad based therapies in transplant eligible patients, such modeling need to be taken with grain of salt Here is why 🧵

Just one of the reasons I love our MM doctors!

Updates from @YiLinMDPhD @HiraSMian @TomBmt133 and the Immune Therapy Committee. Seemingly more questions than answers, aiming for consensus recommendations from the #IMWG scientific community! @IMFmyeloma

Great visual for understanding IMiDs and CELMoDs.

Rome is Burning. Don't say silent. Keep showing up.

Un estudio #multiómico liderado por @BrunoPaiva_UNAV, descarta el papel de células inmaduras en la resistencia al tratamiento oncológico. Como señala @Carmen_gondc, "este estudio concluye que su detección no supone un mayor riesgo de recidiva” cima.cun.es/actualidad/notic…

The U.S. Supreme Court erased all doubts about the sweeping nature of its recent voting rights jurisprudence Tuesday night with a shadow docket ruling that effectively reverses the Court’s own decision in the same matter just three years ago. democracydocket.com/news-ale…

I get a lot of community referrals, and this is a must-read for anyone managing smoldering myeloma in 2026 👇 This #ASCO26 Education Book free access paper by @ASCO covers the full landscape from clinical risk models to immunogenomics, cytogenetics, and the therapeutic implications of early intervention. Key takeaway: risk stratification has evolved far beyond M-protein and plasma cell burden. High-risk SMM is now a treatment indication — the question is how precisely we can identify & treat the appropriate patients Full paper: ascopubs.org/doi/10.1200/EDB… #Myeloma #Hematology @AjayNookaMD @NBahlis @mvmateos @ASCO_pubs

In America today, we rank 34th out of 35 countries in childhood poverty and millions of children are food insecure. Maybe, just maybe, my Republican colleagues would consider holding a single hearing about how we improve the lives of American kids.

Two months ago, when @AOC and I proposed an AI data center moratorium, we were called “Luddites.” Now New York is on the verge of passing a moratorium and dozens of localities are doing the same. People understand: AI must work for all, not just oligarchs.

I absolutely love this street art. 🖼️

Truth.

They're just burning Democracy to the ground. That has always been the Project 2025 Manifesto.

Younger generations don’t understand what a beast of a songwriter this man was. He would write 5 No.1 hits while you were on your 15-min coffee break.

I wear their scorn as a badge of honor.

Myeloma care in India needs focus. On 11th June, we take that step. At FMRI Gurugram, we launch the Centre of Excellence for Myeloma & Lymphoma. For me, this is deeply personal. Some diseases you treat. Some diseases shape the way you think as a hematologist. For me, #MultipleMyeloma has been that disease. Built around focus. Driven by science. Centred on patients. #MultipleMyeloma #Hematology #mmsm

An extremely eloquent and brave man spoke at our survivors event. The sentence he wrote everyday during CART was “ today is a good day”. He went on to say this was either meant to be an affirmation or an aspiration each day ! Always focus on the patients @TischCancer #mmsm